Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
Top Cited Papers
Open Access
- 26 September 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (4), 955-962
- https://doi.org/10.1016/s0735-1097(01)01470-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Renal failure predisposes patients to adverse outcome after coronary artery bypass surgeryKidney International, 1999
- Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failureKidney International, 1998
- Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart DiseaseScandinavian Journal of Urology and Nephrology, 1996
- Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profilesThe American Journal of Cardiology, 1994
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990
- Measurement of renal function in chronic renal diseaseKidney International, 1990
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986